Beliefs about chelation among thalassemia patients

Felicia L Trachtenberg, Lauren Mednick, Janet L Kwiatkowski, Ellis J Neufeld, Dru Haines, Zahra Pakbaz, Alexis A Thompson, Charles T Quinn, Robert Grady, Amy Sobota, Nancy Olivieri, Robert Horne, Robert Yamashita, Thalassemia Clinical Research Network, Felicia L Trachtenberg, Lauren Mednick, Janet L Kwiatkowski, Ellis J Neufeld, Dru Haines, Zahra Pakbaz, Alexis A Thompson, Charles T Quinn, Robert Grady, Amy Sobota, Nancy Olivieri, Robert Horne, Robert Yamashita, Thalassemia Clinical Research Network

Abstract

Background: Understanding patients' views about medication is crucial to maximize adherence. Thalassemia is a congenital blood disorder requiring chronic blood transfusions and daily iron chelation therapy.

Methods: The Beliefs in Medicine Questionnaire (BMQ) was used to assess beliefs in chelation in thalassemia patients from North America and London in the Thalassemia Longitudinal Cohort (TLC) of the Thalassemia Clinical Research Network (TCRN). Chelation adherence was based on patient report of doses administered out of those prescribed in the last four weeks.

Results: Of 371 patients (ages 5-58y, mean 24y), 93% were transfused and 92% receiving chelation (26% deferoxamine (DFO; a slow subcutaneous infusion via portable pump), 63% oral, 11% combination). Patients expressed high "necessity" for transfusion (96%), DFO chelation (92%) and oral chelation (89%), with lower "concern" about treatment (48%, 39%, 19% respectively). Concern about oral chelation was significantly lower than that of DFO (p<0.001). Self-reported adherence to chelation was not associated with views about necessity or concerns, but negatively correlated with perceived sensitivity to DFO (Sensitive Soma scale; r=-0.23, p=0.01) and side effects of oral chelation (r=-0.14, p=0.04). High ferritin iron levels, potentially indicating lower adherence, were found in 41% of patients reporting low necessity of oral chelation compared to 24% reporting high necessity (p=0.048). Concerns about treatment were associated with lower quality of life and more symptoms of anxiety and depression.

Conclusions: Despite their requirement for multimodal therapy, thalassemia patients have positive views about medicine, more so than in other disease populations. Patients may benefit from education about the tolerability of chelation and strategies to effectively cope with side effects, both of which might be beneficial in lowering body iron burden. CLINICALTRIALS.GOV IDENTIFIER: NCT00661804.

References

    1. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a New method for assessing the cognitive representation of medication. Psychol Heal. 1999;14:1–24. doi: 10.1080/08870449908407311.
    1. Horne R, Weinman J. Patients' Beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–567. doi: 10.1016/S0022-3999(99)00057-4.
    1. Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford) 2005;44(6):762–767. doi: 10.1093/rheumatology/keh587.
    1. Bane C, Hughes CM, McElnay JC. The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns. 2006;60(2):187–193. doi: 10.1016/j.pec.2005.01.003.
    1. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18(9):607–613. doi: 10.1038/sj.jhh.1001721.
    1. Horne R, Cooper V, Gellaitry G, Date HL, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr. 2007;45(3):334–341.
    1. Gauchet A, Tarquinio C, Fischer G. Psychosocial predictors of medication adherence among persons living with HIV. Int J Behav Med. 2007;14(3):141–150. doi: 10.1007/BF03000185.
    1. Conn KM, Halterman JS, Fisher SG, Yoos HL, Chin NP, Szilagyi PG. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatr. 2005;5(5):306–310. doi: 10.1367/A05-004R1.1.
    1. Moshkovska T, Stone MA, Clatworthy J, Smith RM, Bankart J, Baker R, Wang J, Horne R, Mayberry JF. An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements. Aliment Pharmacol Ther. 2009;30(11–12):1118–1127.
    1. Jonsdottir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand. 2009;119(1):78–84. doi: 10.1111/j.1600-0447.2008.01279.x.
    1. Tibaldi G, Clatworthy J, Torchio E, Argentero P, Munizza C, Horne R. The utility of the necessity–concerns framework in explaining treatment non-adherence in four chronic illness groups in Italy. Chronic Illn. 2009;5(2):129–133. doi: 10.1177/1742395309102888.
    1. Horne R, Parham R, Driscoll R, Robinson A. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(6):837–844.
    1. Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JA, Horne R. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64(1):47–54. doi: 10.1016/j.jpsychores.2007.07.016.
    1. Mahler C, Hermann K, Horne R, Jank S, Haefeli WE, Szecsenyi J. Patients' Beliefs about medicines in a primary care setting in Germany. J Eval Clin Pract. 2012;18(2):409–413. doi: 10.1111/j.1365-2753.2010.01589.x.
    1. Hedenrud T, Jonsson P, Linde M. Beliefs about medicines and adherence among Swedish migraineurs. Ann Pharmacother. 2008;42(1):39–45.
    1. Horne R, Petrie KJ, Davis C, Diefenbach M, Leventhal H, Leventahl E. The sensitive soma assessment scale (SSAS): a new measure for assessing perceptions of personal sensitivity to medicines. In: Internation Congress of Behavioral Medicine; 2004.
    1. Cook CL, Wade WE, Martin BC, Perri M 3rd. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc. 2005;45(2):151–159. doi: 10.1331/1544345053623573.
    1. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64(1):41–46. doi: 10.1016/j.jpsychores.2007.05.004.
    1. Horne R. Assessing perceptions of medication: psychological perspectives. In: Handbook of Drug research Methodology. UK Drug Utilization Research Group; 2000.
    1. Snaith R, Zigmond A. The hospital anxiety and depression scale manual. London, UK: nferNelson; 1994.
    1. Ware JE, Kosinski M, Bjorner BB, Turner-Bowker D, Gandek B, Maruish ME. User's Manual for the SF-36v2 Health Survey. 2nd. Lincoln, RI: Quality Metric Incorporated; 2007.
    1. Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): A User's Manual. Third Printing. Lincoln: RI: Quality Metric Incorporated; 2006.
    1. Porteous T, Francis J, Bond C, Hannaford P. Temporal stability of beliefs about medicines: implications for optimising adherence. Patient Educ Couns. 2010;79(2):225–230. doi: 10.1016/j.pec.2009.07.037.
    1. Trachtenberg F, Vichinsky E, Foote D, Pakbaz Z, Mednick L, Sobota A, Kwiatkowski J, Thompson AA, Porter J, Coates T, Giardina PJ, Olivieri N, Yamashita R, Neufeld EJ. Iron chelation adherence to deferoxamine and deferasirox in thalassemia. 2010. (in press).
    1. Sobota A, Yamashita R, Xu Y, Trachtenberg F, Kohlbry P, Kleinert DA, Giardina PJ, Kwiatkowski JL, Foote D, Thayalasuthan V. et al.Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms. Am J Hematol. 2011;86(1):92–95. doi: 10.1002/ajh.21896.
    1. Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, Kwiatkowski JL, Foote D, Thayalasuthan V, Porter JB. et al.Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J Hematol. 2010;85(10):802–805. doi: 10.1002/ajh.21826.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner